Sector Alpha Week of 2026-09-18
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-18

CSL Finance Ltd

CSLFINANCE
Finance & Investments - Others

CSL Finance Ltd's earnings have outrun its stock. EPS grew +19.5% in a year against a −27.2% price move.

The sharpest disagreement: annual EPS moved +19.5% against a −27.2% price move — the market has not yet caught up with the delivery.

The price is in a downtrend (57 weeks in) while the P/BV sits at the 25th percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +4.8% year on year, and gross NPA has moved to 0.95%. What settles it: whether the price catches up with earnings that have already moved.

Stage
Consistent
partial read
Price
₹218
−27.2% 1Y
P/BV
0.8×
25th pctile
of its own 11-year range
Revenue (Jun 26)
₹70.0 Cr
+18.6% YoY
Profit (Jun 26)
₹22.0 Cr
+4.8% YoY
Net margin
31.4%
−4.2 pp YoY
ROE
15%
FY26
ROA
8.96%
latest
Gross NPA
0.95%
+0.39 pp YoY
Unverified figures: Some figures on this page come from a second financial-data feed that could not be cross-checked against the primary source — the two do not share enough overlapping reported history to compare. They are drawn, because they are the only evidence there is, and every section carrying one is marked unverified.
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

CSL Finance Ltd trades at ₹218, in a downtrend and 57 weeks into that stage. That is −10.7% against its own 200-day average. It sits at 6% of a 52-week range of ₹212 to ₹318. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (2 weeks and counting).

Today the stock is in a downtrend — week 57 of stage 4, confirmed. At ₹218 it trades −10.7% versus its 200-day average and sits at 6% of its 52-week range (₹212–₹318).

Sep 26: ₹218 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−10.7% versus the 200-day line, week 57 of stage 4
Price50-day avg200-day avg
S2S4S4₹544₹455₹365₹276₹187₹₹218₹245Sep 23Jun 24Apr 25Jan 26Sep 26
S2S4S4₹544₹455₹365₹276₹187₹₹218₹245Sep 23Apr 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (554 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +843% while the NIFTY 500 moved +266% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (2 weeks and counting; last ahead the week of 2026-09-04) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.

CSL Finance Ltd trades at 0.8× P/BV, near the bottom of its own range — cheaper only 25% of the time. Its long-run median P/BV is 1.2×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/BV of 0.8× is near the bottom of its own range — cheaper only 25% of the time, against a long-run median of 1.2× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/BV 0.8× vs a 1.2× long-run median P/BV, weekly (left axis); book value per share, weekly (right axis). 10.5-year window; brief peaks above 2.6× shown pinned at the top. The book value / share bars are red where the reading is lower than the quarter before.
near the bottom of its own range — cheaper only 25% of the time
P/BVMedianBook value / share (quarterly)
2.8×₹2952.1×₹2211.5×₹1470.9×₹73.70.2×₹0.0×₹0.80×₹273Mar 16Nov 18Jul 21Feb 24Sep 26
2.8×₹2952.1×₹2211.5×₹1470.9×₹73.70.2×₹0.0×₹0.80×₹273Mar 16Jul 21Sep 26
P/BV
0.8×
25th percentile of 11y

Why the multiple sits where it does: over the past year book value grew while the price moved −27.2% — price and book moved together, holding the multiple in its range.

The price move, decomposed: over 5y, of the +13.5%/yr price move, ~+16.2%/yr came from book-value growth and ~−2.7 pp from the multiple (compressing); over 10y, of the +13.1%/yr price move, ~+16.7%/yr came from book-value growth and ~−3.6 pp from the multiple (compressing). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is low against its own past, so the story rests on the book-value line underneath it, not the multiple.

03 · What the price assumes

What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.

Solved at its 13 June 2026 price, CSL Finance Ltd was paying for profit growth of about −2.1% a year. Profit itself has compounded 20.8% a year over the past 10 years. Today the market pays 0.8× P/BV, the 25th percentile of its own 11-year range.

What the two numbers say together. The multiple is low against its own past, and the growth the price is paying for is below what this company has actually delivered.

How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 18 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.

04 · Stage: Consistent

Stage: Consistent Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

CSL Finance Ltd reads as consistent on its fundamental arc. Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROE at 15.0% and holding. The read is built from 8 quarters across 4 curves, on partial evidence.

Growth, year by year: revenue +18.5% in FY26, profit +19.4% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
65%70%33%47%1.6%25%−30%3.0%−61%−19%%%18.5%19.4%FY16FY21FY26
65%70%33%47%1.6%25%−30%3.0%−61%−19%%%18.5%19.4%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue stabilising, profit accelerating
RevenueProfitEPS
45%41%38%32%31%24%23%15%16%6.3%%%19.7%14.7%16.1%Sep 23Dec 24Jun 26
45%41%38%32%31%24%23%15%16%6.3%%%19.7%14.7%16.1%Sep 23Dec 24Jun 26
ROE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROE
15.2%14.6%14.0%13.4%12.8%%15%FY23FY24FY26
15.2%14.6%14.0%13.4%12.8%%15%FY23FY24FY26
Revenue growth
Steady high
latest +19.7% · span +18.3% to +42.8%
Profit growth
Steady high
latest +14.7% · span +8.7% to +38.5%
EPS growth
Steady high
latest +16.1% · span +9.2% to +29.0%
ROE
Steady high
latest 15.0% · span 13.0%–15.0%

Why it matters: steady curves with healthy returns are the compounding setup — the risk is the price, not the business.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+18.5%+29.8%+32.8%+19.3%
Profit+19.4%+23.2%+25.2%+20.8%
EPS+19.5%+19.8%+20.5%+15.0%
Share price−27.2%−12.2%+13.5%+13.1%
Revenue YoY (Jun 26)
+18.6%
latest quarter vs a year ago
Profit YoY (Jun 26)
+4.8%
latest quarter vs a year ago
Revenue 10y
19.3%
long-run compound pace
05 · 4-Factor Sector Score

4-Factor Sector Score

60.9/100 — rank 5 of 34 in Finance & Investments - Others · 90% evidence confidence

CSL Finance Ltd scores 60.9 out of 100 against the 34 companies it is compared with in Finance & Investments - Others, ranking 5. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 20.8 + 22.4 + 12 + 5.7 = 60.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.

06 · Revenue

Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.

CSL Finance Ltd reported ₹70.0 Cr of income in the Jun 26 quarter, +18.6% year on year. That is the 11th straight quarter of year-on-year growth. Over 10 years it has compounded at 19.3% a year. The last full year, FY26, came in at ₹256 Cr. The last four reported quarters add to ₹267 Cr.

FY26 revenue came in at ₹256 Cr (+18.5% on the year), capping 10 years at 19.3% compound. The latest quarter (Jun 26) printed ₹70.0 Cr, +18.6% year on year — the 11th consecutive quarter of year-over-year growth.

FY26 revenue ₹256 Cr (+18.5% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
19.3% a year over 10 years
RevenueYoY growth
27665%20733%1381.6%69−30%0−61%₹ Cr%₹25618.5%FY16FY21FY26
27665%20733%1381.6%69−30%0−61%₹ Cr%₹25618.5%FY16FY21FY26
Jun 26: ₹70.0 Cr (+18.6% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
11th straight quarter of growth
Revenue (quarterly)YoY growth
7648%5739%3831%1922%013%₹ Cr%₹7018.6%Sep 23Dec 24Jun 26
7648%5739%3831%1922%013%₹ Cr%₹7018.6%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +19.8% growth against the decade's 19.3% — the current year is running in line with its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +19.7% over the last 4 quarters against +21.5%/yr over the last 8 — stabilising; TTM profit +14.7% vs +11.6%/yr — accelerating.

07 · Net margin

Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.

CSL Finance Ltd's net margin is 31.4% in the Jun 26 quarter, −4.2 percentage points against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 6.1% to 45.2%. The current quarter sits inside that band.

The latest quarter's net margin is 31.4%, −4.2 pp against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 6.1%–45.2%.

Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.

FY26: 33.6% Net margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a 6.1–45.2% band over 13 years
net marginYoY change (pp)
48%23%37%15%26%7.8%14%0.0%3.0%−7.4%%%33.6%0.3%FY14FY20FY26
48%23%37%15%26%7.8%14%0.0%3.0%−7.4%%%33.6%0.3%FY14FY20FY26
Jun 26: 31.4% net margin (−4.2 pp YoY) Quarterly net margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Net profit as a share of total revenue, per quarter.
Net marginYoY change (pp)
41%6.1%38%2.5%34%−1.0%30%−4.5%26%−8.1%%%31.4%−4.2%Sep 23Dec 24Jun 26
41%6.1%38%2.5%34%−1.0%30%−4.5%26%−8.1%%%31.4%−4.2%Sep 23Dec 24Jun 26
08 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

CSL Finance Ltd earned ₹22.0 Cr of net profit in the Jun 26 quarter, +4.8% year on year. Full-year FY26 profit was ₹86.0 Cr. The 10-year compound rate is 20.8%. That is 31.4% of the quarter's revenue. The same quarter a year earlier earned ₹21.0 Cr.

Jun 26 profit was ₹22.0 Cr, +4.8% year on year. On the full year, FY26 printed ₹86.0 Cr (+19.4%), and the 10-year compound rate is 20.8%.

FY26 profit ₹86.0 Cr (+19.4% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
20.8% a year over 10 years
Net profitYoY growth
9368%7048%4627%236.6%0−14%₹ Cr%₹8619.4%FY16FY21FY26
9368%7048%4627%236.6%0−14%₹ Cr%₹8619.4%FY16FY21FY26
Jun 26: ₹22.0 Cr (+4.8% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
2663%1946%1329%612%0−4.7%₹ Cr%₹224.8%Sep 23Dec 24Jun 26
2663%1946%1329%612%0−4.7%₹ Cr%₹224.8%Sep 23Dec 24Jun 26

Why profit moved: revenue contributed +18.6% and the margin −4.2 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit +15.4% vs revenue +19.8%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

09 · Asset quality — the ladder

Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.

CSL Finance Ltd's gross NPA is 0.95% of the loan book in Jun 26, up from 0.56% a year ago. Net of provisions already set aside, 0.60% remains. Across the 12 quarters held here the book has ranged 0.38% to 1.10%. Falling NPAs are a loan book healing; rising NPAs are damage arriving.

Jun 26: gross NPA at 0.95% and net NPA at 0.60%, against 0.56% / 0.42% a year ago. Over the 12 quarters we hold, the book's worst reading was 1.10% and its best is 0.38%.

Fiscal-year ends: gross NPA 0.44% (Mar 24) → 1.10% (Mar 26) Gross and net NPA at each fiscal-year end, % of the loan book (lines). 3 year-ends held. The gap between the two lines is the share already provided for.
Gross NPANet NPA
1.2%0.9%0.7%0.4%0.2%%1.1%0.8%Mar 24Mar 25Mar 26
1.2%0.9%0.7%0.4%0.2%%1.1%0.8%Mar 24Mar 25Mar 26
Jun 26: gross NPA 0.95% (+0.39 pp YoY) Gross and net NPA as % of the loan book, quarterly, last 12 quarters.
Gross NPANet NPA
1.2%0.9%0.7%0.4%0.2%%0.9%0.6%Sep 23Dec 24Jun 26
1.2%0.9%0.7%0.4%0.2%%0.9%0.6%Sep 23Dec 24Jun 26

The synthesis: profit growth at a bank is only as good as the book behind it, and this book is not yet on a clear healing streak. A note on depth: quarterly provisioning detail is not in our numbers yet, so this ladder reads levels and trend, not the cost of the cleanup.

🚨 Why the ladder moved: recoveries, write-offs and slippages each play a part, and that split sits below what we hold — the numbers show the healing; the driver mix does not travel with them.

10 · The loan book

The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.

CSL Finance Ltd's revenue grew +18.5% in FY26 to ₹256 Cr, so the book is growing. The latest quarter ran +18.6% year on year. The net margin on that income is 31.4%, −4.2 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.

FY26 revenue was ₹256 Cr, +18.5% on the year, and the latest quarter ran +18.6% year on year. The net margin on that revenue is 31.4% this quarter (−4.2 pp YoY) — growth with a narrowing margin on it.

FY26: revenue ₹256 Cr (+18.5% YoY) with the net margin at 33.6% Revenue by fiscal year, ₹ Cr (bars, left); net margin, % (line, right). 11-year window. A bar is red when it is lower than the year before.
RevenueNet margin
27646%20742%13837%6933%028%₹ Cr%₹25633.6%FY16FY18FY21FY23FY26
27646%20742%13837%6933%028%₹ Cr%₹25633.6%FY16FY21FY26

The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.

11 · Returns on equity and assets

Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.

CSL Finance Ltd earns a return on equity of 15% in FY26. Its trough over the ladder below was 9% in FY15. On the asset side every ₹100 of the balance sheet earned about ₹8.96, which is the return before leverage is applied.

FY26 ROE came in at 15%, recovered from a FY15 trough of 9%. On assets, the latest reading is about 8.96% — every ₹100 the bank deploys earns roughly ₹8.96 a year. That clears the bar a bank must beat for its book value to compound.

FY26: ROE 15% Return on equity by fiscal year, % (line, left). 13-year window. Latest return on assets: 8.96%. A lender is judged on ROE and ROA — return on invested capital does not apply to a bank.
up from a FY15 trough of 9%
ROE
15%14%12%10%8.5%%15%FY14FY17FY20FY23FY26
15%14%12%10%8.5%%15%FY14FY20FY26

Why ROE moved: profit compounded 20.8% a year over 10 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.

12 · Debt

Debt

For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.

A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.

13 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Foreign institutions cut 2.4 points of CSL Finance Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 0.1% of the company. Domestic institutions moved +2.3 points over the same window, to 3.5%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: −2.4 points over 8 quarters to 0.1%; Domestic institutions: +2.3 points over 8 quarters to 3.5%; Promoters: +0.7 points over 8 quarters to 48.2%.

Why the register moved: rotation — foreign institutions −2.4 points against domestic institutions +2.3 points over 8 quarters, with promoters +0.7 points — one class of institutions handing the register to the other, not a verdict change by the people closest to the numbers.

Fiscal-year ends: promoters −0.1 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
54%39%25%11%−3.8%%47.7%0.2%2.9%48.0%Mar 24Mar 25Mar 26
54%39%25%11%−3.8%%47.7%0.2%2.9%48.0%Mar 24Mar 25Mar 26
Foreign institutions cut 2.4 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
56%41%26%11%−4.1%%48.2%0.1%3.5%46.9%Jun 23Dec 24Jun 26
56%41%26%11%−4.1%%48.2%0.1%3.5%46.9%Jun 23Dec 24Jun 26
14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

CSL Finance Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.

The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.

15 · Related companies · Finance & Investments - Others
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Fedders Holding LtdFEDDERSHOL 74.6/100Favorable setup80% evidence BREAKING OUT 25.1/35 Income -6.4% · PAT 100% 81% evidence 18.3/25 ROA 10.9% · ROE 11.6% · GNPA — 68% evidence 12.2/20 P/BV 1.48× · P/BV÷ROE 0.13 70% evidence 19.0/20 RS sector 17% · RS bench 19.7% · 1Y -6.7%12 of 12 weeks ahead 100% evidence
Exact sum: 25.1 + 18.3 + 12.2 + 19 = 74.6 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
2Abans Financial Services LtdAFSL 70.4/100Favorable setup80% evidence TURNING 24.3/35 Income 100% · PAT 17.9% 81% evidence 14.5/25 ROA 3.6% · ROE 8.3% · GNPA — 68% evidence 16.9/20 P/BV 0.81× · P/BV÷ROE 0.1 100% evidence 14.7/20 RS sector 21% · RS bench 0.6% · 1Y -6.3%0 of 10 weeks ahead 70% evidence
Exact sum: 24.3 + 14.5 + 16.9 + 14.7 = 70.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Gretex Corporate Services LtdGCSL 64.3/100Mixed-positive evidence86% evidence LEADER 24.5/35 Income -19.4% · PAT 100% 81% evidence 18.5/25 ROA 11.5% · ROE 12.7% · GNPA — 68% evidence 1.6/20 P/BV 8.55× · P/BV÷ROE 0.67 100% evidence 19.7/20 RS sector 57.2% · RS bench 62.5% · 1Y 118.4%12 of 12 weeks ahead 100% evidence
Exact sum: 24.5 + 18.5 + 1.6 + 19.7 = 64.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
4Saraswati Commercial (India) LtdZSARACOM 63.0/100Mixed-positive evidence80% evidence BREAKING OUT 30.6/35 Income 100% · PAT 100% 81% evidence 15.2/25 ROA 7.6% · ROE 8.9% · GNPA — 68% evidence 12.0/20 P/BV 1.03× · P/BV÷ROE 0.12 100% evidence 5.2/20 RS sector -17% · RS bench -7.6% · 1Y -19%9 of 9 weeks ahead 70% evidence
Exact sum: 30.6 + 15.2 + 12 + 5.2 = 63 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -17% and the one-year return is -19%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
5CSL Finance Ltdthis pageCSLFINANCE 60.9/100Mixed-positive evidence90% evidence BASING 20.8/35 Income 19.7% · PAT 14.7% 76% evidence 22.4/25 ROA 9% · ROE 14.9% · GNPA 0.9% 95% evidence 12.0/20 P/BV 0.8× · P/BV÷ROE 0.05 100% evidence 5.7/20 RS sector -14.6% · RS bench -12.3% · 1Y -25.6%1 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 22.4 + 12 + 5.7 = 60.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Algoquant Fintech LtdALGOQUANT 60.0/100Mixed-positive evidence74% evidence BREAKING OUT 20.0/35 Income 15.7% · PAT 100% 81% evidence 20.3/25 ROA 12% · ROE 28.4% · GNPA — 68% evidence 4.5/20 P/BV 15.13× · P/BV÷ROE 0.53 70% evidence 15.2/20 RS sector 4.5% · RS bench 19.3% · 1Y 6.7%9 of 10 weeks ahead 70% evidence
Exact sum: 20 + 20.3 + 4.5 + 15.2 = 60 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
7BF Investment LtdBFINVEST 58.6/100Mixed-positive evidence86% evidence ASLEEP 27.3/35 Income 22.2% · PAT 100% 81% evidence 12.1/25 ROA 3% · ROE 3.6% · GNPA — 68% evidence 8.0/20 P/BV 0.2× · P/BV÷ROE 0.06 100% evidence 11.2/20 RS sector 2.1% · RS bench 5% · 1Y -4.3%8 of 12 weeks ahead 100% evidence
Exact sum: 27.3 + 12.1 + 8 + 11.2 = 58.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Master Trust LtdMASTERTR 56.3/100Mixed-positive evidence80% evidence TURNING 13.3/35 Income 7% · PAT 8.1% 81% evidence 18.9/25 ROA 5.6% · ROE 17.3% · GNPA — 68% evidence 15.1/20 P/BV 1.35× · P/BV÷ROE 0.08 70% evidence 9.0/20 RS sector -7.7% · RS bench -5.8% · 1Y -38.8%6 of 12 weeks ahead 100% evidence
Exact sum: 13.3 + 18.9 + 15.1 + 9 = 56.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
9STEL Holdings LtdSTEL 54.3/100Mixed-positive evidence80% evidence BREAKING OUT 25.9/35 Income 20.7% · PAT 21.6% 81% evidence 9.2/25 ROA 1.2% · ROE 1.2% · GNPA — 68% evidence 2.9/20 P/BV 0.75× · P/BV÷ROE 0.64 100% evidence 16.3/20 RS sector 20.5% · RS bench 32.4% · 1Y 24.4%10 of 10 weeks ahead 70% evidence
Exact sum: 25.9 + 9.2 + 2.9 + 16.3 = 54.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Dolat Algotech LtdDOLATALGO 52.4/100Mixed-positive evidence80% evidence ASLEEP 8.5/35 Income -11.6% · PAT -21.2% 81% evidence 18.1/25 ROA 8.5% · ROE 12.1% · GNPA — 68% evidence 17.2/20 P/BV 1.05× · P/BV÷ROE 0.09 100% evidence 8.6/20 RS sector -0.8% · RS bench -10.4% · 1Y -21.1%0 of 10 weeks ahead 70% evidence
Exact sum: 8.5 + 18.1 + 17.2 + 8.6 = 52.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
11Bengal & Assam Company LtdBENGALASM 52.0/100Mixed-positive evidence64% evidence 16.7/35 Income 12.1% · PAT 3.4% 62% evidence 12.8/25 ROA — · ROE 8.1% · GNPA — 34% evidence 16.0/20 P/BV 0.66× · P/BV÷ROE 0.08 100% evidence 6.5/20 RS sector -9.4% · RS bench -4.3% · 1Y -29.4%1 of 8 weeks ahead 70% evidence
Exact sum: 16.7 + 12.8 + 16 + 6.5 = 52 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Mufin Green Finance LtdMUFIN 51.8/100Mixed-positive evidence82% evidence FADING 24.0/35 Income 27.8% · PAT 100% 86% evidence 11.2/25 ROA 1.3% · ROE 6.7% · GNPA — 72% evidence 4.0/20 P/BV 4.59× · P/BV÷ROE 0.69 70% evidence 12.6/20 RS sector 12.3% · RS bench 16% · 1Y 49.6%10 of 12 weeks ahead 100% evidence
Exact sum: 24 + 11.2 + 4 + 12.6 = 51.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Balmer Lawrie Investment LtdBLIL 51.3/100Mixed-positive evidence86% evidence ASLEEP 14.8/35 Income 8.8% · PAT 4.1% 81% evidence 18.3/25 ROA 7.9% · ROE 12.7% · GNPA — 68% evidence 13.8/20 P/BV 1.04× · P/BV÷ROE 0.08 100% evidence 4.4/20 RS sector -9.2% · RS bench -6.5% · 1Y -28.1%0 of 12 weeks ahead 100% evidence
Exact sum: 14.8 + 18.3 + 13.8 + 4.4 = 51.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
14PTC India Financial Services LtdPFS 51.2/100Mixed-positive evidence80% evidence ASLEEP 12.4/35 Income -22.7% · PAT -27.8% 81% evidence 16.9/25 ROA 6.5% · ROE 11% · GNPA — 68% evidence 15.8/20 P/BV 0.55× · P/BV÷ROE 0.05 100% evidence 6.1/20 RS sector -7.1% · RS bench -15.3% · 1Y -29.8%0 of 10 weeks ahead 70% evidence
Exact sum: 12.4 + 16.9 + 15.8 + 6.1 = 51.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
15Consolidated Finvest & Holdings LtdCONSOFINVT 47.8/100Mixed-negative evidence86% evidence BREAKING OUT 8.1/35 Income -9.1% · PAT -43.9% 81% evidence 13.7/25 ROA 4.3% · ROE 5% · GNPA — 68% evidence 7.1/20 P/BV 0.84× · P/BV÷ROE 0.17 100% evidence 18.9/20 RS sector 35% · RS bench 39.8% · 1Y 55%12 of 12 weeks ahead 100% evidence
Exact sum: 8.1 + 13.7 + 7.1 + 18.9 = 47.8 · Decision use: Price leads the evidence: RS versus the benchmark is 39.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
16Finkurve Financial Services LtdFINKURVE 45.3/100Mixed-negative evidence74% evidence BREAKING OUT 21.0/35 Income 59.6% · PAT 62.2% 81% evidence 14.1/25 ROA 2.1% · ROE 9.4% · GNPA — 68% evidence 6.0/20 P/BV 2.97× · P/BV÷ROE 0.32 70% evidence 4.2/20 RS sector -34.3% · RS bench -8.9% · 1Y -29.3%5 of 11 weeks ahead 70% evidence
Exact sum: 21 + 14.1 + 6 + 4.2 = 45.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Industrial & Prudential Investment Company LtdINDPRUD 44.8/100Mixed-negative evidence80% evidence BASING 12.5/35 Income -40% · PAT -3.2% 81% evidence 15.6/25 ROA 7.3% · ROE 7.7% · GNPA — 68% evidence 6.3/20 P/BV 1.23× · P/BV÷ROE 0.16 100% evidence 10.4/20 RS sector -3.5% · RS bench 4.2% · 1Y -6%0 of 10 weeks ahead 70% evidence
Exact sum: 12.5 + 15.6 + 6.3 + 10.4 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18PTL Enterprises LtdPTL 44.4/100Mixed-negative evidence75% evidence ASLEEP 16.4/35 Income 0% · PAT 13.5% 52% evidence 13.8/25 ROA 3.3% · ROE 5.5% · GNPA — 68% evidence 8.0/20 P/BV 0.6× · P/BV÷ROE 0.11 100% evidence 6.2/20 RS sector -4.5% · RS bench -1.5% · 1Y -3.7%1 of 12 weeks ahead 100% evidence
Exact sum: 16.4 + 13.8 + 8 + 6.2 = 44.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19VLS Finance LtdVLSFINANCE 43.4/100Mixed-negative evidence80% evidence ASLEEP 18.1/35 Income -8.4% · PAT 91.7% 81% evidence 7.5/25 ROA 1% · ROE 0.9% · GNPA — 68% evidence 4.9/20 P/BV 0.35× · P/BV÷ROE 0.37 100% evidence 12.9/20 RS sector 9.4% · RS bench -3.4% · 1Y 8.1%3 of 10 weeks ahead 70% evidence
Exact sum: 18.1 + 7.5 + 4.9 + 12.9 = 43.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Authum Investment & Infrastructure LtdAIIL 43.2/100Mixed-negative evidence70% evidence BREAKING OUT 8.6/35 Income -34.6% · PAT -48.8% 62% evidence 15.2/25 ROA — · ROE 12.8% · GNPA — 34% evidence 5.3/20 P/BV 3.23× · P/BV÷ROE 0.25 100% evidence 14.1/20 RS sector 3.6% · RS bench 6.4% · 1Y -10.7%9 of 12 weeks ahead 100% evidence
Exact sum: 8.6 + 15.2 + 5.3 + 14.1 = 43.2 · Decision use: Price leads the evidence: RS versus the benchmark is 6.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
21PNB Gilts LtdPNBGILTS 41.3/100Mixed-negative evidence80% evidence ASLEEP 9.1/35 Income -5.3% · PAT -69.7% 81% evidence 9.8/25 ROA 0.7% · ROE 11% · GNPA — 68% evidence 15.3/20 P/BV 0.83× · P/BV÷ROE 0.07 100% evidence 7.1/20 RS sector -13.5% · RS bench -1.9% · 1Y -19.9%4 of 10 weeks ahead 70% evidence
Exact sum: 9.1 + 9.8 + 15.3 + 7.1 = 41.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
22NBI Industrial Finance Company LtdNBIFIN 40.3/100Mixed-negative evidence69% evidence TURNING 20.8/35 Income 55.5% · PAT 65.2% 33% evidence 6.1/25 ROA 0.3% · ROE 0.4% · GNPA — 68% evidence 4.7/20 P/BV 0.22× · P/BV÷ROE 0.52 100% evidence 8.7/20 RS sector -7.5% · RS bench -5.1% · 1Y -23.2%5 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 6.1 + 4.7 + 8.7 = 40.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Capital India Finance LtdCIFL 39.8/100Thin evidence · provisional57% evidence BASING 17.7/35 Income -1.5% · PAT 100% 52% evidence 8.8/25 ROA 1.7% · ROE -8.6% · GNPA — 68% evidence 9.2/20 P/BV 1.16× · P/BV÷ROE — 40% evidence 4.1/20 RS sector -17.3% · RS bench -28.9% · 1Y -41.7%0 of 10 weeks ahead 70% evidence
Exact sum: 17.7 + 8.8 + 9.2 + 4.1 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
24Prime Securities LtdPRIMESECU 38.9/100Mixed-negative evidence86% evidence TURNING 8.9/35 Income 14.4% · PAT -80% 81% evidence 13.4/25 ROA 4.6% · ROE 4.1% · GNPA — 68% evidence 3.2/20 P/BV 3.93× · P/BV÷ROE 0.96 100% evidence 13.4/20 RS sector 3.9% · RS bench 7% · 1Y 13.4%0 of 12 weeks ahead 100% evidence
Exact sum: 8.9 + 13.4 + 3.2 + 13.4 = 38.9 · Decision use: Price leads the evidence: RS versus the benchmark is 7%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
25Grand Oak Canyons Distillery LtdGRANDOAK 38.3/100Mixed-negative evidence71% evidence ASLEEP 23.4/35 Income 100% · PAT 100% 54% evidence 4.0/25 ROA 0.1% · ROE 0% · GNPA — 72% evidence 0.7/20 P/BV 2.09× · P/BV÷ROE 209 100% evidence 10.2/20 RS sector 2% · RS bench -6.7% · 1Y -14.8%9 of 10 weeks ahead 70% evidence
Exact sum: 23.4 + 4 + 0.7 + 10.2 = 38.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26The Investment Trust of India LtdTHEINVEST 37.6/100Mixed-negative evidence75% evidence BASING 11.7/35 Income -22.4% · PAT -13.9% 52% evidence 11.9/25 ROA 2.7% · ROE 4% · GNPA — 68% evidence 8.0/20 P/BV 0.67× · P/BV÷ROE 0.17 100% evidence 6.0/20 RS sector -14.9% · RS bench -12.7% · 1Y -38%0 of 12 weeks ahead 100% evidence
Exact sum: 11.7 + 11.9 + 8 + 6 = 37.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Nalwa Sons Investments LtdNSIL 36.4/100Mixed-negative evidence76% evidence BASING 18.8/35 Income -20.3% · PAT 37.2% 86% evidence 5.9/25 ROA 0.3% · ROE 0.3% · GNPA — 72% evidence 5.0/20 P/BV 0.19× · P/BV÷ROE 0.56 70% evidence 6.7/20 RS sector -6.7% · RS bench -8% · 1Y -23%0 of 10 weeks ahead 70% evidence
Exact sum: 18.8 + 5.9 + 5 + 6.7 = 36.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Crest Ventures LtdCREST 35.4/100Mixed-negative evidence86% evidence ASLEEP 7.1/35 Income -33.2% · PAT -49.3% 81% evidence 12.4/25 ROA 2.5% · ROE 3.8% · GNPA — 68% evidence 8.0/20 P/BV 0.8× · P/BV÷ROE 0.21 100% evidence 7.9/20 RS sector -1.6% · RS bench 1.3% · 1Y -3%1 of 12 weeks ahead 100% evidence
Exact sum: 7.1 + 12.4 + 8 + 7.9 = 35.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
29Kiran Vyapar LtdKIRANVYPAR 32.8/100Adverse evidence64% evidence BREAKING OUT 10.2/35 Income 0.9% · PAT -80% 62% evidence 7.3/25 ROA 1.1% · ROE 0.1% · GNPA — 68% evidence 3.4/20 P/BV 0.25× · P/BV÷ROE 5 100% evidence 11.9/20 RS sector — · RS bench 8% · 1Y —5 of 8 weeks ahead 25% evidence
Exact sum: 10.2 + 7.3 + 3.4 + 11.9 = 32.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
30Dhunseri Investments LtdDHUNINV 31.3/100Adverse evidence73% evidence BREAKING OUT 15.5/35 Income -12.3% · PAT 17.1% 62% evidence 5.0/25 ROA -0.5% · ROE 0.7% · GNPA — 68% evidence 5.3/20 P/BV 0.22× · P/BV÷ROE 0.33 100% evidence 5.5/20 RS sector -34.7% · RS bench -2% · 1Y -29.6%6 of 6 weeks ahead 70% evidence
Exact sum: 15.5 + 5 + 5.3 + 5.5 = 31.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
31Systematix Corporate Services LtdSYSTMTXC 29.3/100Adverse evidence74% evidence TURNING 9.4/35 Income 14.4% · PAT -80% 81% evidence 12.4/25 ROA 3.2% · ROE 4.6% · GNPA — 68% evidence 4.1/20 P/BV 3.22× · P/BV÷ROE 0.7 70% evidence 3.4/20 RS sector -38.5% · RS bench -19.5% · 1Y -40.1%2 of 10 weeks ahead 70% evidence
Exact sum: 9.4 + 12.4 + 4.1 + 3.4 = 29.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
32Oswal Green Tech LtdOSWALGREEN 27.0/100Adverse evidence75% evidence BASING 8.8/35 Income -46.8% · PAT -80% 52% evidence 8.0/25 ROA 1.1% · ROE 1.1% · GNPA — 68% evidence 8.0/20 P/BV 0.21× · P/BV÷ROE 0.19 100% evidence 2.2/20 RS sector -30.8% · RS bench -29.1% · 1Y -51.1%0 of 12 weeks ahead 100% evidence
Exact sum: 8.8 + 8 + 8 + 2.2 = 27 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
33Spice Lounge Food Works LtdSPICELOUNG 44.3/100Thin evidence · provisional44% evidence 20.2/35 Income 20.9% · PAT 100% 22% evidence 12.0/25 ROA — · ROE 8.4% · GNPA — 34% evidence 3.3/20 P/BV 15.85× · P/BV÷ROE 1.9 70% evidence 8.8/20 RS sector 0.7% · RS bench -20.9% · 1Y -37%2 of 12 weeks ahead to 2026-08-23 70% evidence
Exact sum: 20.2 + 12 + 3.3 + 8.8 = 44.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
34Eraaya Lifespaces LtdEBIX 39.5/100Thin evidence · provisional22% evidence 17.5/35 Income — · PAT — 0% evidence 9.3/25 ROA — · ROE -809% · GNPA — 26% evidence 9.2/20 P/BV 6.36× · P/BV÷ROE — 10% evidence 3.5/20 RS sector -34.1% · RS bench -39.5% · 1Y -41.4%8 of 12 weeks ahead to 2026-03-08 70% evidence
Exact sum: 17.5 + 9.3 + 9.2 + 3.5 = 39.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is CSL Finance Ltd's share price today?

CSL Finance Ltd trades at ₹218, −27.2% over the past year. The company is valued at ₹497 Cr. The stock sits at 6% of its 52-week range of ₹212–₹318, −10.7% versus its 200-day average. On the tape, the price is in a downtrend, 57 weeks in. — as of 18 September 2026.

What were CSL Finance Ltd's latest quarterly results?

CSL Finance Ltd reported total income of ₹70.0 Cr and net profit of ₹22.0 Cr for the Jun 26 quarter. Income rose 18.6% and profit rose 4.8% year on year. Earnings per share were ₹9.72. The net margin was 31.4%, 4.2 pp lower than a year earlier. — as of 18 September 2026.

What is CSL Finance Ltd's revenue?

CSL Finance Ltd reported revenue of ₹70.0 Cr in the Jun 26 quarter, +18.6% year on year. For the full FY26 fiscal year, revenue was ₹256 Cr (+18.5%). Over the last 10 years revenue compounded at 19.3% a year. — as of 18 September 2026.

What is CSL Finance Ltd's profit?

CSL Finance Ltd earned ₹22.0 Cr of net profit in the Jun 26 quarter, +4.8% year on year. Full-year FY26 profit was ₹86.0 Cr. The net margin ran 31.4% in the latest quarter. — as of 18 September 2026.

What is CSL Finance Ltd's market cap?

CSL Finance Ltd's market capitalisation is ₹497 Cr at a share price of ₹218. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 18 September 2026.

What is CSL Finance Ltd's P/BV ratio?

CSL Finance Ltd trades at a P/BV of 0.8×, at the 25th percentile of its own 11-year range, against a long-run median of 1.2×. This is a comparison with the stock's own history, not a value call — as of 18 September 2026.

Does CSL Finance Ltd pay a dividend?

Yes — CSL Finance Ltd's dividend payout was 26% of profit in FY26, and it recorded a payout in 10 of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 18 September 2026.

Is CSL Finance Ltd overvalued?

On its own history, CSL Finance Ltd looks cheap: its P/BV of 0.8× has been cheaper only 25% of the time in 11 years (long-run median 1.2×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 18 September 2026.

Is CSL Finance Ltd growing?

Yes — CSL Finance Ltd is growing: latest-quarter revenue +18.6% year on year, profit +4.8%, and the net margin −4.2 pp at 31.4%. The 10-year compound rates are 19.3% (revenue) and 20.8% (profit). The earnings engine currently reads: improving — as of 18 September 2026.

How is CSL Finance Ltd performing?

CSL Finance Ltd is in a downtrend, 57 weeks in. Its latest quarter's income rose 18.6% and profit rose 4.8% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 2 weeks. This describes what the data did, not a rating. — as of 18 September 2026.

What stage is CSL Finance Ltd in?

Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROE at 15.0% and holding. The read comes from the last 12 quarters of growth (revenue growth +19.7% latest, profit growth +14.7% latest, eps growth +16.1% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 18 September 2026.

Is CSL Finance Ltd in an uptrend?

No — the price is in a downtrend (week 57 of stage 4), trading −10.7% versus its 200-day average and at 6% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 18 September 2026.

Is CSL Finance Ltd beating the market?

Not lately — on a trailing-13-week view CSL Finance Ltd is currently behind the NIFTY 500 (2 weeks and counting; last ahead the week of 2026-09-04), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +843% against the NIFTY 500's +266% — ahead of the index over the full window. — as of 18 September 2026.

Will CSL Finance Ltd's share price go up?

This page publishes no price forecast for CSL Finance Ltd. What it measures instead: the share price is ₹218, the price is in a downtrend 57 weeks in. Its P/BV of 0.8× sits at the 25th percentile of its own 11-year range. — as of 18 September 2026.

Who owns CSL Finance Ltd?

Promoters hold 48.2% of CSL Finance Ltd, foreign institutions 0.1%, domestic institutions 3.5% and the public 46.9% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 2.4 points over 8 quarters. — as of 18 September 2026.

Is CSL Finance Ltd's loan book healthy?

Gross NPA is 0.95% of CSL Finance Ltd's loan book, up from 0.56% a year ago, and net NPA stands at 0.60%. Falling NPAs are a loan book healing; rising NPAs are damage arriving — as of 18 September 2026.

Where is CSL Finance Ltd in its business cycle?

CSL Finance Ltd's FY26 net margin was 33.6%, against a 13-year band of 6.1%–45.2%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 31.4%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 18 September 2026.

What growth does CSL Finance Ltd's price assume?

At its price on 13 June 2026, CSL Finance Ltd was priced for profit growth of about −2.1% a year. Profit itself has compounded 20.8% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 18 September 2026.

What could break the CSL Finance Ltd story?

The sharpest disagreement: annual EPS moved +19.5% against a −27.2% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 18 September 2026.

Is CSL Finance Ltd a stock worth studying right now?

This is not investment advice. The machine read: CSL Finance Ltd's earnings have outrun its stock. EPS grew +19.5% in a year against a −27.2% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 18 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-18. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI